How Will Physicians Respond to the Next Influenza Pandemic?

被引:20
|
作者
Fedson, David S.
机构
关键词
pandemic influenza; statins; immunomodulatory agents; public health; RECEPTOR BLOCKERS; HUMAN INFECTIONS; VIRUS; MORTALITY; STATINS; SURVIVAL; A(H7N9); VACCINE; METABOLISM; CHALLENGES;
D O I
10.1093/cid/cit695
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The emergence of the H7N9 virus in China is another reminder of the threat of a global influenza pandemic. Many believe we could confront a pandemic by expanding our capacity to provide timely supplies of affordable pandemic vaccines and antiviral agents. Experience in 2009 demonstrated that this cannot and will not be done. Consequently, physicians may have little more to offer their patients than they had in the 1918 pandemic. Fortunately, several modern drugs (eg, statins, angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors) can modify the host response to inflammatory illness, and laboratory and clinical studies suggest they might be used to treat pandemic patients. Unfortunately, little attention has been given to the research needed to support their use in patient care. There is no guarantee these drugs will work, but physicians will never know unless those responsible for pandemic preparedness recognize and act on the extraordinary possibility that they might save lives.
引用
收藏
页码:233 / 237
页数:5
相关论文
共 50 条
  • [41] Understanding influenza transmission, immunity and pandemic threats
    Mathews, John D.
    Chesson, Joanne M.
    McCaw, James M.
    McVernon, Jodie
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2009, 3 (04) : 143 - 149
  • [42] A global pandemic influenza vaccine action plan
    Kieny, Marie Paule
    Costa, Alejandro
    Hombach, Joachim
    Carrasco, Peter
    Pervikov, Yuri
    Salisbury, David
    Greco, Michel
    Gust, Ian
    LaForce, Marc
    Franco-Paredes, Carlos
    Santos, Jose Ignacio
    D'Hondt, Eric
    Rimmelzwaan, Guus
    Karron, Ruth
    Fukuda, Keiji
    VACCINE, 2006, 24 (40-41) : 6367 - 6370
  • [43] PANDEMIC INFLUENZA: MODELLING AND PUBLIC HEALTH PERSPECTIVES
    Arino, Julien
    Bauch, Chris
    Brauer, Fred
    Driedger, S. Michelle
    Greer, Amy L.
    Moghadas, Seyed M.
    Pizzi, Nick J.
    Sander, Beate
    Tuite, Ashleigh
    van den Driessche, P.
    Watmough, James
    Wu, Jianhong
    Yan, Ping
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2011, 8 (01) : 1 - 20
  • [44] Spatial Transmission of 2009 Pandemic Influenza in the US
    Gog, Julia R.
    Ballesteros, Sebastien
    Viboud, Cecile
    Simonsen, Lone
    Bjornstad, Ottar N.
    Shaman, Jeffrey
    Chao, Dennis L.
    Khan, Farid
    Grenfell, Bryan T.
    PLOS COMPUTATIONAL BIOLOGY, 2014, 10 (06)
  • [45] Historical Review of Pandemic Influenza A in Taiwan, 2009
    Ho, Tzong-Shiann
    Wang, Shih-Min
    Liu, Ching-Chuan
    PEDIATRICS AND NEONATOLOGY, 2010, 51 (02): : 83 - 88
  • [46] Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories
    Kelso, Joel K.
    Halder, Nilimesh
    Postma, Maarten J.
    Milne, George J.
    BMC PUBLIC HEALTH, 2013, 13
  • [47] The Pandemic Influenza 1918
    Salzberger, Bernd
    Mohr, Arno
    Hitzenbichler, Florian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (25) : 1858 - 1863
  • [48] Prediction of pandemic influenza
    Hiroshi Nishiura
    European Journal of Epidemiology, 2011, 26 : 583 - 584
  • [49] Prediction of pandemic influenza
    Nishiura, Hiroshi
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2011, 26 (07) : 583 - 584
  • [50] Pandemic (avian) influenza
    Rajagopal, Sumanth
    Treanor, John
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (02) : 159 - 170